An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more effectively and a much lower cost ...

One of the first and most promising uses scientists envision for the rapidly evolving technology of quantum computing is a new approach to drug development.

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...

GBAC “Quantum Healthcare 2025” board blueprint—$3.2 B QC drug-discovery market, 42 % CAGR, 50–70 % faster R&D cycles ...

Microfluidic contact lenses (MCLs) are redefining what it means to see clearly—by doing much more than correcting vision.

Johnson & Johnson's recent earnings beat expectations, with strong Medicine and MedTech growth. Read why I have a buy rating ...

The pharmacy automation devices market is experiencing steady growth, with a projected CAGR of approximately 8-9% during the ...

BMY stock offers value with a sub-7x P/E, 6% dividend yield, and strong earnings. Discover why it’s a compelling buy despite ...

PITTSBURGH, May 27, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today issued the following statement regarding its dispute with Renovaro, In ...

Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise ...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, ...